Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: Pharmacotherapy. 2010 Mar;30(3):228–235. doi: 10.1592/phco.30.3.228

Table 2.

Blood pressure values and blood pressure control at each time period

Variable Baseline 9 month
(clinical trial)
18 month
(9-month post-
Clinical trial)
27 month
(18-month
post clinical
Trial)
Control (n=39)
   SBP 150.1 ±9.6 132.0 ±15.1* 143.3 ±17.5** 141.2 ±15.8**
   DBP 85.4 ±10.7 79.1 ±11.7 75.7 ±9.5 77.1 ±11.3
  BP control (%) 0 48.7%# 30.8%## 35.9%§
Intervention (n=65)
   SBP 152.5 ±9.5 124.5 ±10.7* 131.0 ±12.2** 131.3 ±13.0**
   DBP 85.5 ±12.2 75.2 ±10.2 77.1 ±8.7 76.3 ±11.7
  BP control (%)* 0 78.5%# 53.9%## 55.3%§

BP control defined as <130/80 mm Hg for patients with diabetes or chronic kidney disease and <140/90 for non-diabetic patients.

Between group differences:

*

p = 0.0038;

**

p < 0.001;

#

p=0.0017,

##

p=0.02,

§

p=0.05